BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lopez R, Dauvilliers Y. Pharmacotherapy options for cataplexy. Expert Opin Pharmacother 2013;14:895-903. [PMID: 23521426 DOI: 10.1517/14656566.2013.783021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S. Exploring the Role of Orexinergic Neurons in Parkinson's Disease. Neurotox Res 2021. [PMID: 34495449 DOI: 10.1007/s12640-021-00411-4] [Reference Citation Analysis]
2 Franceschini C, Pizza F, Cavalli F, Plazzi G. A practical guide to the pharmacological and behavioral therapy of Narcolepsy. Neurotherapeutics 2021;18:6-19. [PMID: 33886090 DOI: 10.1007/s13311-021-01051-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Peregrim I, Grešová S, Štimmelová J, Bačová I, Fulton B, Tokárová D, Gáborová M, Brandeburová A, Doničová V, Rusnáková S, Tomori Z, Donič V. Strong Coincidence Between Slow Wave Sleep and Low AHI is Explainable by the High Instability of Slow Wave Sleep to Obstructive Apnea Exposure. Physiol Res. [DOI: 10.33549/physiolres.934025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Franceschini C, Pizza F, Antelmi E, Folli MC, Plazzi G. Narcolepsy treatment: pharmacological and behavioral strategies in adults and children. Sleep Breath 2020;24:615-27. [PMID: 31290083 DOI: 10.1007/s11325-019-01894-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Economou NT, Ferini-Strambi L, Steiropoulos P. Sleep-Related Drug Therapy in Special Conditions: Children. Sleep Med Clin 2018;13:251-62. [PMID: 29759275 DOI: 10.1016/j.jsmc.2018.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kotagal S. Treatment of narcolepsy and other organic hypersomnias in children. Paediatric Respiratory Reviews 2018;25:19-24. [DOI: 10.1016/j.prrv.2017.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
7 Lopez R, Barateau L, Evangelista E, Dauvilliers Y. Depression and Hypersomnia: A Complex Association. Sleep Med Clin 2017;12:395-405. [PMID: 28778237 DOI: 10.1016/j.jsmc.2017.03.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
8 Barateau L, Lopez R, Dauvilliers Y. Treatment Options for Narcolepsy. CNS Drugs 2016;30:369-79. [PMID: 27155860 DOI: 10.1007/s40263-016-0337-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]
9 Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. French consensus. Management of patients with hypersomnia: Which strategy? Revue Neurologique 2017;173:8-18. [DOI: 10.1016/j.neurol.2016.09.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
10 Moresco M, Riccardi LN, Pizza F, Zenesini C, Caporali L, Plazzi G, Pelotti S. Pharmacogenetics and Treatment Response in Narcolepsy Type 1: Relevance of the Polymorphisms of the Drug Transporter Gene ABCB1. Clin Neuropharmacol 2016;39:18-23. [PMID: 26757307 DOI: 10.1097/WNF.0000000000000119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Barateau L, Lopez R, Dauvilliers Y. Management of Narcolepsy. Curr Treat Options Neurol 2016;18. [DOI: 10.1007/s11940-016-0429-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
12 Duchêne A, Perier M, Zhao Y, Liu X, Thomasson J, Chauveau F, Piérard C, Lagarde D, Picoli C, Jeanson T, Mouthon F, Dauvilliers Y, Giaume C, Lin JS, Charvériat M. Impact of Astroglial Connexins on Modafinil Pharmacological Properties. Sleep 2016;39:1283-92. [PMID: 27091533 DOI: 10.5665/sleep.5854] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
13 Khan Z, Trotti LM. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest 2015;148:262-73. [PMID: 26149554 DOI: 10.1378/chest.14-1304] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
14 Lee EK, Douglass AB. Baclofen for narcolepsy with cataplexy: two cases. Nat Sci Sleep 2015;7:81-3. [PMID: 26251634 DOI: 10.2147/NSS.S86649] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Thorpy MJ, Dauvilliers Y. Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Medicine 2015;16:9-18. [DOI: 10.1016/j.sleep.2014.10.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 11.0] [Reference Citation Analysis]
16 Çak HT, Haliloğlu G, Düzgün G, Yüce A, Topçu M. Successful treatment of cataplexy in patients with early-infantile Niemann–Pick disease type C: Use of tricyclic antidepressants. European Journal of Paediatric Neurology 2014;18:811-5. [DOI: 10.1016/j.ejpn.2014.07.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fonseca Hde A, Lopes DA, Pereira D, Sguillar DA, Lopes E, Behrens NS, Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM. The use of citalopram for the treatment of cataplexy. Sleep Sci 2014;7:50-2. [PMID: 26483901 DOI: 10.1016/j.slsci.2014.07.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]